{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE1", "ACE2", "Sub-Saharan Africa", "ethno-medicinal plants", "hypertension", "renin\u2013angiotensin system"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32366012", "DateCompleted": {"Year": "2021", "Month": "02", "Day": "09"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "04", "Day": "30"}], "Language": ["eng"], "ELocationID": ["2114", "10.3390/molecules25092114"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "9", "PubDate": {"Year": "2020", "Month": "Apr", "Day": "30"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "An Overview of the Potential Use of Ethno-Medicinal Plants Targeting the Renin-Angiotensin System in the Treatment of Hypertension.", "Abstract": {"AbstractText": ["The development of risk factors associated with cardiovascular disorders present a major public health challenge in both developed countries and countries with emerging economies. Hypertension and associated complications including stroke and myocardial infarction have reached pandemic levels. Current management strategies of hypertension predominantly include the utilization of pharmaceutical drugs which are often associated with undesirable side effects. Moreover, the drugs are often too expensive for populations from resource-limited Southern African rural, and some urban, communities. As a result, most patients rely on ethno-medicinal plants for the treatment of a variety of diseases including cardiovascular and metabolic disorders. The effectiveness of these plants in managing several cardiovascular diseases has been attributed to the presence of bioactive phytochemical constituents. In this review, the treatment options that target the renin-angiotensin system (RAS) in the management of hypertension were summarized, with special emphasis on ethno-medicinal plants and their influence on the ACE1 RAS pathway. The dearth of knowledge regarding the effect of ethno-medicinal plants on the ACE2 pathway was also highlighted."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy and Physiology, University of Johannesburg, Doornfontein Campus, Corner Beit and Siemert Streets, Doornfontein, Johannesburg 2000, South Africa."}], "LastName": "De Lange-Jacobs", "ForeName": "Pietro", "Initials": "P"}, {"Identifier": ["0000-0002-4396-4788"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy and Physiology, University of Johannesburg, Doornfontein Campus, Corner Beit and Siemert Streets, Doornfontein, Johannesburg 2000, South Africa."}], "LastName": "Shaikh-Kader", "ForeName": "Asma", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy and Physiology, University of Johannesburg, Doornfontein Campus, Corner Beit and Siemert Streets, Doornfontein, Johannesburg 2000, South Africa."}], "LastName": "Thomas", "ForeName": "Bianca", "Initials": "B"}, {"Identifier": ["0000-0003-1872-9257"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy and Physiology, University of Johannesburg, Doornfontein Campus, Corner Beit and Siemert Streets, Doornfontein, Johannesburg 2000, South Africa."}, {"Identifier": [], "Affiliation": "Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria 0002, South Africa."}], "LastName": "Nyakudya", "ForeName": "Trevor T", "Initials": "TT"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 3.4.15.1", "NameOfSubstance": "Peptidyl-Dipeptidase A"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}, {"RegistryNumber": "EC 3.6.5.2", "NameOfSubstance": "ras Proteins"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": [], "DescriptorName": "Drug Development"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hypertension"}, {"QualifierName": [], "DescriptorName": "Medicine, Traditional"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptidyl-Dipeptidase A"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Renin-Angiotensin System"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "ras Proteins"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Olshansky S.J., Passaro D.J., Hershow R.C., Layden J., Carnes B.A., Brody J., Hayflick L., Butler R.N., Allison D.B., Ludwig D.S. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 2005;352:1138\u20131145. doi: 10.1056/NEJMsr043743.", "ArticleIdList": ["10.1056/NEJMsr043743", "15784668"]}, {"Citation": "James P.A., Oparil S., Carter B.L., Cushman W.C., Dennison-Himmelfarb C., Handler J., Lackland D.T., LeFevre M.L., MacKenzie T.D., Ogedegbe O. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA. 2014;311:507\u2013520. doi: 10.1001/jama.2013.284427.", "ArticleIdList": ["10.1001/jama.2013.284427", "24352797"]}, {"Citation": "Cappuccio F.P., Miller M.A. Cardiovascular disease and hypertension in sub-Saharan Africa: Burden, risk and interventions. Intern. Emerg. Med. 2016;11:299\u2013305. doi: 10.1007/s11739-016-1423-9.", "ArticleIdList": ["10.1007/s11739-016-1423-9", "PMC4820479", "27001886"]}, {"Citation": "Lloyd-Sherlock P., Beard J., Minicuci N., Ebrahim S., Chatterji S. Hypertension among older adults in low-and middle-income countries: Prevalence, awareness and control. Int. J. Epidemiol. 2014;43:116\u2013128. doi: 10.1093/ije/dyt215.", "ArticleIdList": ["10.1093/ije/dyt215", "PMC3937973", "24505082"]}, {"Citation": "Hughes G.D., Aboyade O.M., Clark B.L., Puoane T.R. The prevalence of traditional herbal medicine use among hypertensives living in South African communities. BMC Complement. Altern. Med. 2013;13:38.", "ArticleIdList": ["PMC3598715", "23414344"]}, {"Citation": "Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217\u2013223. doi: 10.1016/S0140-6736(05)17741-1.", "ArticleIdList": ["10.1016/S0140-6736(05)17741-1", "15652604"]}, {"Citation": "Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., Lin J.K., Farzadfar F., Khang Y.-H., Stevens G.A. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b7 7 million participants. Lancet. 2011;378:31\u201340. doi: 10.1016/S0140-6736(11)60679-X.", "ArticleIdList": ["10.1016/S0140-6736(11)60679-X", "21705069"]}, {"Citation": "Opie L.H., Seedat Y.K. Hypertension in sub-Saharan African populations. Circulation. 2005;112:3562\u20133568. doi: 10.1161/CIRCULATIONAHA.105.539569.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.105.539569", "16330697"]}, {"Citation": "Alsheikh-Ali A.A., Omar M.I., Raal F.J., Rashed W., Hamoui O., Kane A., Alami M., Abreu P., Mashhoud W.M. Cardiovascular risk factor burden in Africa and the middle east: The Africa middle east cardiovascular epidemiological (ACE) study. PLoS ONE. 2014;9:e102830. doi: 10.1371/journal.pone.0102830.", "ArticleIdList": ["10.1371/journal.pone.0102830", "PMC4121128", "25090638"]}, {"Citation": "Organization, W.H. Global Status Report on Noncommunicable Diseases 2014. World Health Organization; Geneva, Switzerland: 2014."}, {"Citation": "Seedat Y., Rayner B. South African hypertension guideline 2011. Samj S. Afr. Med J. 2012;102:60\u201383. doi: 10.1080/20786204.2012.10874201.", "ArticleIdList": ["10.1080/20786204.2012.10874201", "22273141"]}, {"Citation": "Duncan A.C., J\u00e4ger A.K., van Staden J. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. J. Ethnopharmacol. 1999;68:63\u201370. doi: 10.1016/S0378-8741(99)00097-5.", "ArticleIdList": ["10.1016/S0378-8741(99)00097-5", "10624863"]}, {"Citation": "Steyn K., Bradshaw D., Norman R., Laubscher R. Determinants and treatment of hypertension in South Africans: The first Demographic and Health Survey. S. Afr. Med. J. 2008;98:376\u2013380.", "ArticleIdList": ["18637309"]}, {"Citation": "Connor M., Rheeder P., Bryer A., Meredith M., Beukes M., Dubb A., Fritz V. The South African stroke risk in general practice study. S. Afr. Med. J. 2005;95", "ArticleIdList": ["15931448"]}, {"Citation": "Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000;275:33238\u201333243. doi: 10.1074/jbc.M002615200.", "ArticleIdList": ["10.1074/jbc.M002615200", "10924499"]}, {"Citation": "Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R. A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000;87:e1\u2013e9. doi: 10.1161/01.RES.87.5.e1.", "ArticleIdList": ["10.1161/01.RES.87.5.e1", "10969042"]}, {"Citation": "Santos R.A., Ferreira A.J., Verano-Braga T., Bader M. Angiotensin-converting enzyme 2, angiotensin-(1\u20137) and Mas: New players of the renin\u2013angiotensin system. J. Endocrinol. 2013;216:R1\u2013R17. doi: 10.1530/JOE-12-0341.", "ArticleIdList": ["10.1530/JOE-12-0341", "23092879"]}, {"Citation": "McKinney C.A., Fattah C., Loughrey C.M., Milligan G., Nicklin S.A. Angiotensin-(1\u20137) and angiotensin-(1\u20139): Function in cardiac and vascular remodelling. Clin. Sci. 2014;126:815\u2013827. doi: 10.1042/CS20130436.", "ArticleIdList": ["10.1042/CS20130436", "24593683"]}, {"Citation": "Katovich M.J., Grobe J.L., Huentelman M., Raizada M.K. Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension. Exp. Physiol. 2005;90:299\u2013305. doi: 10.1113/expphysiol.2004.028522.", "ArticleIdList": ["10.1113/expphysiol.2004.028522", "15640278"]}, {"Citation": "Yamazato M., Yamazato Y., Sun C., Diez-Freire C., Raizada M.K. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension. 2007;49:926\u2013931. doi: 10.1161/01.HYP.0000259942.38108.20.", "ArticleIdList": ["10.1161/01.HYP.0000259942.38108.20", "17325232"]}, {"Citation": "Varagic J., Ahmad S., Brosnihan K.B., Groban L., Chappell M.C., Tallant E.A., Gallagher P.E., Ferrario C.M. Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction. Ther. Adv. Cardiovasc. Dis. 2010;4:17\u201325. doi: 10.1177/1753944709353337.", "ArticleIdList": ["10.1177/1753944709353337", "PMC3733447", "19946038"]}, {"Citation": "Santos R.A., Ferreira A.J., e Silva A.C.S. Recent advances in the angiotensin-converting enzyme 2\u2013angiotensin (1\u20137)\u2013Mas axis. Exp. Physiol. 2008;93:519\u2013527. doi: 10.1113/expphysiol.2008.042002.", "ArticleIdList": ["10.1113/expphysiol.2008.042002", "18310257"]}, {"Citation": "Ferreira A.J., Santos R.A., Almeida A.P. Angiotensin-(1-7): Cardioprotective effect in myocardial ischemia/reperfusion. Hypertension. 2001;38:665\u2013668. doi: 10.1161/01.HYP.38.3.665.", "ArticleIdList": ["10.1161/01.HYP.38.3.665", "11566952"]}, {"Citation": "Zhong J.-C., Huang D.-Y., Yang Y.-M., Li Y.-F., Liu G.-F., Song X.-H., Du K. Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension. 2004;44:907\u2013912. doi: 10.1161/01.HYP.0000146400.57221.74.", "ArticleIdList": ["10.1161/01.HYP.0000146400.57221.74", "15477383"]}, {"Citation": "Popescu S.M., Scrieciu M., Mercu\u0163 V., \u0162uculina M., Dasc\u0103lu I. Hypertensive patients and their management in dentistry. ISRN Hypertens. 2013:2013. doi: 10.5402/2013/410740.", "ArticleIdList": ["10.5402/2013/410740"]}, {"Citation": "Doumas M., Tsakiris A., Douma S., Grigorakis A., Papadopoulos A., Hounta A., Tsiodras S., Dimitriou D., Giamarellou H. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J. Androl. 2006;27:469\u2013477. doi: 10.2164/jandrol.04191.", "ArticleIdList": ["10.2164/jandrol.04191", "16339456"]}, {"Citation": "Trinder Y. Common and less common adverse effects of antihypertensives: A general practitioner\u2019s perspective: SA Hypertension Society Supplement. S. Afr. Fam. Pract. 2012;54:31\u201332. doi: 10.1080/20786204.2012.10874209.", "ArticleIdList": ["10.1080/20786204.2012.10874209"]}, {"Citation": "Liwa A.C. Herbal and Alternative Medicine Utilization in Tanzanian Adults Admitted with Hypertension-Related Conditions. Weill Medical College of Cornell University; New York, NY, USA: 2015."}, {"Citation": "Opie L.H. Calcium channel antagonists in the treatment of coronary artery disease: Fundamental pharmacological properties relevant to clinical use. Prog. Cardiovasc. Dis. 1996;38:273\u2013290. doi: 10.1016/S0033-0620(96)80014-4.", "ArticleIdList": ["10.1016/S0033-0620(96)80014-4", "8552787"]}, {"Citation": "Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol. Asp. Med. 2006;27:1\u201393. doi: 10.1016/j.mam.2005.07.008.", "ArticleIdList": ["10.1016/j.mam.2005.07.008", "16105678"]}, {"Citation": "Reid A.-M., Oosthuizen C.B., Fibrich B.D., Twilley D., Lambrechts I.A., de Canha M.N., Rademan S., Lall N. Medicinal Plants for Holistic Health and Well-Being. Elsevier; Amsterdam, The Netherlands: 2018. Traditional Medicine: The Ancient Roots of Modern Practice; pp. 1\u201311."}, {"Citation": "Verma R., Hanif K., Sasmal D., Raghubir R. Resurgence of herbal antihypertensives in management of hypertension. Curr. Hypertens. Rev. 2010;6:190\u2013198. doi: 10.2174/157340210791936705.", "ArticleIdList": ["10.2174/157340210791936705"]}, {"Citation": "Eddouks M., Maghrani M., Lemhadri A., Ouahidi M.-L., Jouad H. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet) J. Ethnopharmacol. 2002;82:97\u2013103. doi: 10.1016/S0378-8741(02)00164-2.", "ArticleIdList": ["10.1016/S0378-8741(02)00164-2", "12241983"]}, {"Citation": "Taylor J., Rabe T., McGaw L., J\u00e4ger A., Van Staden J. Towards the scientific validation of traditional medicinal plants. Plant Growth Regul. 2001;34:23\u201337. doi: 10.1023/A:1013310809275.", "ArticleIdList": ["10.1023/A:1013310809275"]}, {"Citation": "De Wet H., Ramulondi M., Ngcobo Z. The use of indigenous medicine for the treatment of hypertension by a rural community in northern Maputaland, South Africa. S. Afr. J. Bot. 2016;103:78\u201388. doi: 10.1016/j.sajb.2015.08.011.", "ArticleIdList": ["10.1016/j.sajb.2015.08.011"]}, {"Citation": "Mackraj I., Ramesar S., Singh R.T. T. Violacea Lowers Blood Pressure and down Regulates AT1a Gene Expression in a Hypertensive Rat Model. FASEB J. 2007;21:A1247."}, {"Citation": "Somova L., Shode F., Ramnanan P., Nadar A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J. Ethnopharmacol. 2003;84:299\u2013305. doi: 10.1016/S0378-8741(02)00332-X.", "ArticleIdList": ["10.1016/S0378-8741(02)00332-X", "12648829"]}, {"Citation": "Ramesar S., Baijnath H., Govender T., Mackraj I. Angiotensin I-converting enzyme inhibitor activity of nutritive plants in KwaZulu-Natal. J. Med. Food. 2008;11:331\u2013336. doi: 10.1089/jmf.2007.569.", "ArticleIdList": ["10.1089/jmf.2007.569", "18598177"]}, {"Citation": "Mackraj I., Ramesar S. ACE Inhibitor Activity of Nutritive Plants in Kwa-Zulu Natal. FASEB J. 2007;21:A1247.", "ArticleIdList": ["18598177"]}, {"Citation": "Raji I.A., Mugabo P., Obikeze K. Effect of Tulbaghia violacea on the blood pressure and heart rate in male spontaneously hypertensive Wistar rats. J. Ethnopharmacol. 2012;140:98\u2013106. doi: 10.1016/j.jep.2011.12.034.", "ArticleIdList": ["10.1016/j.jep.2011.12.034", "22222281"]}, {"Citation": "Raji I., Obikeze K., Mugabo P. Potential beneficial effects of Tulbaghia violacea William Henry Harvey (Alliaceae) on cardiovascular system-A review. Trop. J. Pharm. Res. 2015;14:1111\u20131117. doi: 10.4314/tjpr.v14i6.25.", "ArticleIdList": ["10.4314/tjpr.v14i6.25"]}, {"Citation": "Persson I.A.L. The Pharmacological Mechanism of Angiotensin-converting Enzyme Inhibition by Green Tea, Rooibos and Enalaprilat\u2013A Study on Enzyme Kinetics. Phytother. Res. 2012;26:517\u2013521. doi: 10.1002/ptr.3588.", "ArticleIdList": ["10.1002/ptr.3588", "22095883"]}, {"Citation": "Preuss H.G., Clouatre D., Mohamadi A., Jarrell S.T. Wild garlic has a greater effect than regular garlic on blood pressure and blood chemistries of rats. Int. Urol. Nephrol. 2001;32:525\u2013530. doi: 10.1023/A:1014417526290.", "ArticleIdList": ["10.1023/A:1014417526290", "11989540"]}, {"Citation": "Sikora J., Markowicz-Piasecka M., Broncel M., Mikiciuk-Olasik E. Extract of Aronia melanocarpa-modified hemostasis: In vitro studies. Eur. J. Nutr. 2014;53:1493\u20131502. doi: 10.1007/s00394-014-0653-8.", "ArticleIdList": ["10.1007/s00394-014-0653-8", "PMC4175040", "24452534"]}, {"Citation": "Lacaille-Dubois M., Franck U., Wagner H. Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine. 2001;8:47\u201352. doi: 10.1078/0944-7113-00003.", "ArticleIdList": ["10.1078/0944-7113-00003", "11292239"]}, {"Citation": "Brixius K., Willms S., Napp A., Tossios P., Ladage D., Bloch W., Mehlhorn U., Schwinger R.H. Crataegus special extract WS\u00ae 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc. Drugs Ther. 2006;20:177\u2013184. doi: 10.1007/s10557-006-8723-7.", "ArticleIdList": ["10.1007/s10557-006-8723-7", "16779533"]}, {"Citation": "Rawat P., Singh P.K., Kumar V. Anti-hypertensive medicinal plants and their mode of action. J. Herb. Med. 2016;6:107\u2013118. doi: 10.1016/j.hermed.2016.06.001.", "ArticleIdList": ["10.1016/j.hermed.2016.06.001"]}, {"Citation": "Caballero-George C., Vanderheyden P.M., De Bruyne T., Shahat A.-A., Van den Heuvel H., Solis P.N., Gupta M.P., Claeys M., Pieters L., Vauquelin G. In vitro inhibition of [3H]-angiotensin II binding on the human AT1 receptor by proanthocyanidins from Guazuma ulmifolia bark. Planta Med. 2002;68:1066\u20131071. doi: 10.1055/s-2002-36344.", "ArticleIdList": ["10.1055/s-2002-36344", "12494331"]}, {"Citation": "Ojeda D., Jim\u00e9nez-Ferrer E., Zamilpa A., Herrera-Arellano A., Tortoriello J., Alvarez L. Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin-and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J. Ethnopharmacol. 2010;127:7\u201310. doi: 10.1016/j.jep.2009.09.059.", "ArticleIdList": ["10.1016/j.jep.2009.09.059", "19808084"]}, {"Citation": "Jabeen Q., Aslam N. Hypotensive, angiotensin converting enzyme (ACE) inhibitory and diuretic activities of the aqueous-methanol extract of Ipomoea reniformis. Iran. J. Pharm. Res. IJPR. 2013;12:769.", "ArticleIdList": ["PMC3920690", "24523757"]}, {"Citation": "Jaarin K., Foong W.D., Yeoh M.H., Kamarul Z.Y.N., Qodriyah H.M.S., Azman A., Zuhair J.S.F., Juliana A.H., Kamisah Y. Mechanisms of the antihypertensive effects of Nigella sativa oil in L-NAME-induced hypertensive rats. Clinics. 2015;70:751\u2013757. doi: 10.6061/clinics/2015(11)07.", "ArticleIdList": ["10.6061/clinics/2015(11)07", "PMC4642492", "26602523"]}, {"Citation": "Shaw H.-M., Wu J.-L., Wang M.-S. Antihypertensive effects of Ocimum gratissimum extract: Angiotensin-converting enzyme inhibitor in vitro and in vivo investigation. J. Funct. Foods. 2017;35:68\u201373. doi: 10.1016/j.jff.2017.05.033.", "ArticleIdList": ["10.1016/j.jff.2017.05.033"]}, {"Citation": "Msomi N.Z., Simelane M.B. Active Ingredients from Aromatic and Medicinal Plants. InTech; London, UK: 2017. Olea europaea subsp. africana (Oleaceae)"}, {"Citation": "Saputri F., Mun\u2019im A., Lukmanto D., Aisyah S., Rinandy J. Inhibition of angiotensin converting enzyme (ACE) activity by some Indonesia edible plants. Int. J. Pharm. Sci. Res. 2015;6:1054\u20131059."}, {"Citation": "Xie Y., Zhang W. Antihypertensive activity of Rosa rugosa Thunb. flowers: Angiotensin I converting enzyme inhibitor. J. Ethnopharmacol. 2012;144:562\u2013566. doi: 10.1016/j.jep.2012.09.038.", "ArticleIdList": ["10.1016/j.jep.2012.09.038", "23063753"]}, {"Citation": "Huh M.K. Inhibition of Angiotensin Converting Enzyme (ACE) by Viola Mandshurica Extraction. Eur. J. Adv. Res. Biol. Life Sci. Vol. 2015;3"}, {"Citation": "Yodjun M., Karnchanatat A., Sangvanich P. Angiotensin I-converting enzyme inhibitory proteins and peptides from the rhizomes of Zingiberaceae plants. Appl. Biochem. Biotechnol. 2012;166:2037\u20132050. doi: 10.1007/s12010-012-9630-y.", "ArticleIdList": ["10.1007/s12010-012-9630-y", "22391695"]}, {"Citation": "Rentzsch B., Todiras M., Iliescu R., Popova E., Campos L.A., Oliveira M.L., Baltatu O.C., Santos R.A., Bader M. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension. 2008;52:967\u2013973. doi: 10.1161/HYPERTENSIONAHA.108.114322.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.108.114322", "18809792"]}, {"Citation": "D\u00edez-Freire C., V\u00e1zquez J., de Adjounian M.F.C., Ferrari M.F., Yuan L., Silver X., Torres R., Raizada M.K. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol. Genom. 2006;27:12\u201319. doi: 10.1152/physiolgenomics.00312.2005.", "ArticleIdList": ["10.1152/physiolgenomics.00312.2005", "16788004"]}, {"Citation": "Phillips M.I., Sumners C. Angiotensin II in central nervous system physiology. Regul. Pept. 1998;78:1\u201311. doi: 10.1016/S0167-0115(98)00122-0.", "ArticleIdList": ["10.1016/S0167-0115(98)00122-0", "9879741"]}, {"Citation": "Paizis G., Tikellis C., Cooper M.E., Schembri J.M., Lew R.A., Smith A.I., Shaw T., Warner F.J., Zuilli A., Burrell L.M. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54:1790\u20131796. doi: 10.1136/gut.2004.062398.", "ArticleIdList": ["10.1136/gut.2004.062398", "PMC1774784", "16166274"]}, {"Citation": "Doobay M.F., Talman L.S., Obr T.D., Tian X., Davisson R.L., Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol. -Regul. Integr. Comp. Physiol. 2007 doi: 10.1152/ajpregu.00292.2006.", "ArticleIdList": ["10.1152/ajpregu.00292.2006", "PMC1761128", "16946085"]}, {"Citation": "Liu C.X., Hu Q., Wang Y., Zhang W., Ma Z.Y., Feng J.B., Wang R., Wang X.P., Dong B., Gao F. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: A comparison with ACE inhibition. Mol. Med. 2011;17:59\u201369. doi: 10.2119/molmed.2010.00111.", "ArticleIdList": ["10.2119/molmed.2010.00111", "PMC3022989", "20844835"]}, {"Citation": "Diz D.I., Garcia-Espinosa M.A., Gegick S., Tommasi E.N., Ferrario C.M., Tallant E.A., Chappell M.C., Gallagher P.E. Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats. Exp. Physiol. 2008;93:694\u2013700. doi: 10.1113/expphysiol.2007.040261.", "ArticleIdList": ["10.1113/expphysiol.2007.040261", "PMC2704611", "18356558"]}, {"Citation": "Chamsi-Pasha M.A., Shao Z., Tang W.W. Angiotensin-converting enzyme 2 as a therapeutic target for heart failure. Curr. Heart Fail. Rep. 2014;11:58\u201363. doi: 10.1007/s11897-013-0178-0.", "ArticleIdList": ["10.1007/s11897-013-0178-0", "PMC3944399", "24293035"]}, {"Citation": "Huentelman M.J., Grobe J.L., Vazquez J., Stewart J.M., Mecca A.P., Katovich M.J., Ferrario C.M., Raizada M.K. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp. Physiol. 2005;90:783\u2013790. doi: 10.1113/expphysiol.2005.031096.", "ArticleIdList": ["10.1113/expphysiol.2005.031096", "16049057"]}, {"Citation": "Chappell M.C., Modrall J., Diz D.I., Ferrario C. Novel aspects of the renal renin-angiotensin system: Angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib. Nephrol. 2004;143:77\u201389.", "ArticleIdList": ["15248357"]}, {"Citation": "Bai S., Huang Z.-G., Chen L., Wang J.-T., Ding B.-P. Effects of felodipine combined with puerarin on ACE2\u2013Ang (1\u20137)\u2013Mas axis in renovascular hypertensive rat. Regul. Pept. 2013;184:54\u201361. doi: 10.1016/j.regpep.2013.03.005.", "ArticleIdList": ["10.1016/j.regpep.2013.03.005", "23523569"]}, {"Citation": "Qiao W., Wang C., Chen B., Zhang F., Liu Y., Lu Q., Guo H., Yan C., Sun H., Hu G. Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology. 2015;131:97\u2013106. doi: 10.1159/000375362.", "ArticleIdList": ["10.1159/000375362", "25896805"]}, {"Citation": "Arumugam S., Thandavarayan R.A., Palaniyandi S.S., Giridharan V.V., Arozal W., Sari F.R., Soetikno V., Harima M., Suzuki K., Kodama M. Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: Involvement of ACE2-Ang (1\u20137)-mas axis. Toxicology. 2012;291:139\u2013145. doi: 10.1016/j.tox.2011.11.008.", "ArticleIdList": ["10.1016/j.tox.2011.11.008", "22120037"]}, {"Citation": "Cao L., Xun J., Jiang X., Tan R. Propofol up-regulates Mas receptor expression in dorsal root ganglion neurons. Die Pharm. Int. J. Pharm. Sci. 2013;68:677\u2013680.", "ArticleIdList": ["24020123"]}, {"Citation": "Sukumaran V., Veeraveedu P.T., Gurusamy N., Lakshmanan A.P., Yamaguchi K.I., Ma M., Suzuki K., Kodama M., Watanabe K. Telmisartan acts through the modulation of ACE-2/ANG 1\u20137/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis. Life Sci. 2012;90:289\u2013300. doi: 10.1016/j.lfs.2011.11.018.", "ArticleIdList": ["10.1016/j.lfs.2011.11.018", "22210452"]}, {"Citation": "Hern\u00e1ndez Prada J.A., Ferreira A.J., Katovich M.J., Shenoy V., Qi Y., Santos R.A., Castellano R.K., Lampkins A.J., Gubala V., Ostrov D.A. Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension. 2008;51:1312\u20131317. doi: 10.1161/HYPERTENSIONAHA.107.108944.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.107.108944", "18391097"]}, {"Citation": "Flores-Monroy J., Ferrario C.M., Valencia-Hern\u00e1ndez I., Hern\u00e1ndez-Campos M.E., Mart\u00ednez-Aguilar L. Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction. Pharmacology. 2014;94:21\u201328. doi: 10.1159/000365093.", "ArticleIdList": ["10.1159/000365093", "25171296"]}, {"Citation": "Wang Y., Li C., Ouyang Y., Yu J., Guo S., Liu Z., Li D., Han J., Wang W. Cardioprotective effects of Qishenyiqi mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin-converting enzyme 2. Evid. Based Complement. Altern. Med. 2012;2012 doi: 10.1155/2012/978127.", "ArticleIdList": ["10.1155/2012/978127", "PMC3526154", "23304234"]}, {"Citation": "Liu Q., Tian J., Xu Y., Li C., Meng X., Fu F. Protective effect of RA on myocardial infarction-induced cardiac fibrosis via AT1R/p38 MAPK pathway signaling and modulation of the ACE2/ACE ratio. J. Agric. Food Chem. 2016;64:6716\u20136722. doi: 10.1021/acs.jafc.6b03001.", "ArticleIdList": ["10.1021/acs.jafc.6b03001", "27538767"]}, {"Citation": "Zhang S., Xiangqun L., Huanqin C., Xin Y., Qiongqiong G., Min W., Xingpo L. Effects of Baicalin on the NF-\u03baB and ACE2 Protein Expression in Atherosclerosis of ApoE-/-Mice Induced by Hyperlipaemia. Med. Plant. 2013;4"}, {"Citation": "Tabassum N., Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn. Rev. 2011;5:30. doi: 10.4103/0973-7847.79097.", "ArticleIdList": ["10.4103/0973-7847.79097", "PMC3210006", "22096316"]}, {"Citation": "Wilburn A.J., King D.S., Glisson J., Rockhold R.W., Wofford M.R. The natural treatment of hypertension. J. Clin. Hypertens. 2004;6:242\u2013248. doi: 10.1111/j.1524-6175.2004.03250.x.", "ArticleIdList": ["10.1111/j.1524-6175.2004.03250.x", "PMC8109646", "15133406"]}, {"Citation": "Sofowora A. Medicinal Plants and Traditional Medicine in Africa. Karthala; Paris, France: 1982.", "ArticleIdList": ["9395671"]}, {"Citation": "Balick M.J., Cox P.A. Plants, People, and Culture: The Science of Ethnobotany. Scientific American Library; New York, NY, USA: 1996."}, {"Citation": "Kumar S., Kaushik G., Dar M.A., Nimesh S., Lopez-Chuken U.J., Villarreal-Chiu J.F. Microbial degradation of organophosphate pesticides: A review. Pedosphere. 2018;28:190\u2013208. doi: 10.1016/S1002-0160(18)60017-7.", "ArticleIdList": ["10.1016/S1002-0160(18)60017-7"]}, {"Citation": "Quinn L., de Vos J., Fernandes-Whaley M., Roos C., Bouwman H., Kylin H., Pieters R., van den Berg J. Pesticides in the Modern World\u2014Pesticides Use and Management. IntechOpen; London, UK: 2011. Pesticide use in South Africa: One of the largest importers of pesticides in Africa."}, {"Citation": "WHO . WHO Monographs on Selected Medicinal Plants. Volume 2 World Health Organization; Geneva, Switzerland: 1999."}, {"Citation": "Rates S.M.K. Plants as source of drugs. Toxicon. 2001;39:603\u2013613. doi: 10.1016/S0041-0101(00)00154-9.", "ArticleIdList": ["10.1016/S0041-0101(00)00154-9", "11072038"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "3", "Day": "19"}, {"Year": "2020", "Month": "4", "Day": "15"}, {"Year": "2020", "Month": "4", "Day": "22"}, {"Year": "2020", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["32366012", "PMC7249071", "10.3390/molecules25092114", "molecules25092114"]}}], "PubmedBookArticle": []}